XYZAL levocetirizine dihydrochloride 5 mg/mL oral drops bottle

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

levocetirizine dihydrochloride, Quantity: 5 mg/mL

Disponible depuis:

UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia

DCI (Dénomination commune internationale):

levocetirizine dihydrochloride

forme pharmaceutique:

Oral Liquid

Composition:

Excipient Ingredients: purified water; propylene glycol; glycerol; acetic acid; saccharin sodium; methyl hydroxybenzoate; propyl hydroxybenzoate; sodium acetate

Mode d'administration:

Oral

Unités en paquet:

1 x 15mL bottle, 1 x 20mL bottle, 1 x 10 mL bottle

Type d'ordonnance:

(S2) Pharmacy Medicine

indications thérapeutiques:

Xyzal oral drops are indicated for the symptomatic treatment of allergic rhinitis (including persistent rhinitis) and chronic idiopathic urticaria in adults and children aged 2 years and over.

Descriptif du produit:

Visual Identification: Clear, colourless solution; Container Type: Bottle; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Statut de autorisation:

Registered

Date de l'autorisation:

2010-01-19